UB Paderborn / Katalog / Suche / in CDI

Phase III Trial Comparing Docetaxel and Cisplatin Combination Chemotherapy With Mitomycin, Vindesine, and Cisplatin Combination Chemotherapy With Concurrent Thoracic Radiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: OLCSG 0007

Journal of clinical oncology, 2010-07, Vol.28 (20), p.3299-3306

2010

Link zum Volltext

Verfügbarkeit prüfen

Diffuse Parenchymal Pulmonary Amyloidosis Showing an Objective Response to Bortezomib-based Chemotherapy

Internal Medicine, 2014, Vol.53(16), pp.1809-1812

2014

Link zum Volltext

Verfügbarkeit prüfen

Protocol Design for the Bench to Bed Trial in Alectinib-Refractory Non-Small-Cell Lung Cancer Patients Harboring the EML4-ALK Fusion Gene (ALRIGHT/OLCSG1405)

Clinical lung cancer, 2016-11, Vol.17 (6), p.602-605

2016

Link zum Volltext

Verfügbarkeit prüfen

A phase I trial of afatinib and bevacizumab in chemo-naïve patients with advanced non-small-cell lung cancer harboring EGFR mutations: Okayama Lung Cancer Study Group Trial 1404

Lung cancer (Amsterdam, Netherlands), 2018-01, Vol.115, p.103-108

2018

Link zum Volltext

Verfügbarkeit prüfen

A triplet chemotherapy with cisplatin, docetaxel and gemcitabine in patients with advanced non-small-cell lung cancer : a phase I/II study

Cancer chemotherapy and pharmacology, 2007-06, Vol.60 (1), p.53-59

2007

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors in advanced non-small cell lung cancer: elevated serum levels of neuron specific enolase indicate poor prognosis

Japanese journal of clinical oncology, 2000-12, Vol.30 (12), p.534-541

2000

Link zum Volltext

Verfügbarkeit prüfen

Successful Treatment of a Patient with Synchronous Advanced Non-small Cell Lung Cancer and Acute Myeloid Leukemia by a Combination of Gefitinib, Low-dose Cytarabine and Aclarubicin

Anticancer research, 2005-05, Vol.25 (3C), p.2579-2582

2005

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of cisplatin plus S-1 with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer: The Okayama Lung Cancer Study Group Trial 0501

Lung cancer (Amsterdam, Netherlands), 2015-02, Vol.87 (2), p.141-147

2015

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of amrubicin and topotecan combination therapy in patients with relapsed or extensive-disease small-cell lung cancer: Okayama Lung Cancer Study Group Trial 0401

Lung cancer (Amsterdam, Netherlands), 2011-10, Vol.74 (1), p.80-84

2011

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of irinotecan and amrubicin in patients with relapsed non-small cell lung cancer: Okayama Lung Cancer Study Group Trial 0402

Acta oncologica, 2012-07, Vol.51 (6), p.768-773

2012

Link zum Volltext

Verfügbarkeit prüfen

A phase I and pharmacological study of amrubicin and topotecan in patients of small-cell lung cancer with relapsed or extensive-disease small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2006-08, Vol.53 (2), p.189-195

2006

Link zum Volltext

Verfügbarkeit prüfen

Triple Combination Chemotherapy with Cisplatin, Docetaxel, and Irinotecan for Advanced Non-small Cell Lung Cancer: A Phase I/II Trial

Journal of thoracic oncology, 2007-01, Vol.2 (1), p.44-50

2007

Link zum Volltext

Verfügbarkeit prüfen

A phase I study of 3-day topotecan and cisplatin in elderly patients with small-cell lung cancer

Cancer chemotherapy and pharmacology, 2006-06, Vol.57 (6), p.755-760

2006

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors of small-cell lung cancer in Okayama Lung Cancer Study Group Trials

Acta medica Okayama, 1998-04, Vol.52 (2), p.105-111

1998

Link zum Volltext

Verfügbarkeit prüfen

Pilot study of cyclophosphamide‐doxorubicin‐vincristine‐cisplatin‐etoposide hybrid chemotherapy in small cell lung cancer

Cancer, 1993-09, Vol.72 (5), p.1597-1601

1993

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Phase III Trial Comparing Docetaxel and Cisplatin Combination Chemotherapy With Mitomycin, Vindesine, and Cisplatin Combination Chemotherapy With Concurrent Thoracic Radiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: OLCSG 0007

Diffuse Parenchymal Pulmonary Amyloidosis Showing an Objective Response to Bortezomib-based Chemotherapy

Protocol Design for the Bench to Bed Trial in Alectinib-Refractory Non-Small-Cell Lung Cancer Patients Harboring the EML4-ALK Fusion Gene (ALRIGHT/OLCSG1405)

A phase I trial of afatinib and bevacizumab in chemo-naïve patients with advanced non-small-cell lung cancer harboring EGFR mutations: Okayama Lung Cancer Study Group Trial 1404

A triplet chemotherapy with cisplatin, docetaxel and gemcitabine in patients with advanced non-small-cell lung cancer : a phase I/II study

Prognostic factors in advanced non-small cell lung cancer: elevated serum levels of neuron specific enolase indicate poor prognosis

Successful Treatment of a Patient with Synchronous Advanced Non-small Cell Lung Cancer and Acute Myeloid Leukemia by a Combination of Gefitinib, Low-dose Cytarabine and Aclarubicin

Phase 2 Study of Afatinib Alone or Combined With Bevacizumab in Chemonaive Patients With Advanced Non–Small-Cell Lung Cancer Harboring EGFR Mutations: AfaBev-CS Study Protocol

A phase II study of cisplatin plus S-1 with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer: The Okayama Lung Cancer Study Group Trial 0501

A phase II study of amrubicin and topotecan combination therapy in patients with relapsed or extensive-disease small-cell lung cancer: Okayama Lung Cancer Study Group Trial 0401

Phase II study of irinotecan and amrubicin in patients with relapsed non-small cell lung cancer: Okayama Lung Cancer Study Group Trial 0402

A phase I and pharmacological study of amrubicin and topotecan in patients of small-cell lung cancer with relapsed or extensive-disease small-cell lung cancer

Triple Combination Chemotherapy with Cisplatin, Docetaxel, and Irinotecan for Advanced Non-small Cell Lung Cancer: A Phase I/II Trial

A phase I study of 3-day topotecan and cisplatin in elderly patients with small-cell lung cancer

Prognostic factors of small-cell lung cancer in Okayama Lung Cancer Study Group Trials

Pilot study of cyclophosphamide‐doxorubicin‐vincristine‐cisplatin‐etoposide hybrid chemotherapy in small cell lung cancer

Aktive Filter

Suchergebnisse filtern